Sterol Regulatory Element Binding Protein-1c Expression and Action in Rat Muscles: Insulin-Like Effects on the Control of Glycolytic and Lipogenic Enzymes and UCP3 Gene Expression
- Isabelle Guillet-Deniau1,
- Virginie Mieulet1,
- Soazig Le Lay2,
- Younes Achouri2,
- Denis Carré1,
- Jean Girard1,
- Fabienne Foufelle2 and
- Pascal Ferré2
- 1UPR 1524 CNRS, Institut Cochin de Génétique Moléculaire, Paris, France
- 2Unité INSERM 465, Centre de Recherches Biomédicales des Cordeliers, Université Paris VI, Paris, France
Abstract
Sterol regulatory element binding protein-1c (SREBP-1c) is a transcription factor that mediates insulin effects on hepatic gene expression. It is itself transcriptionally stimulated by insulin in hepatocytes. Here we show that SREBP-1c mRNA is expressed in adult rat skeletal muscles and that this expression is decreased by diabetes. The regulation of SREBP-1c expression was then assessed in cultures of adult muscle satellite cells. These cells form spontaneously contracting multinucleated myotubes within 7 days of culture. SREBP-1c mRNA is expressed in contracting myotubes. A 4-h treatment with 100 nmol/l insulin increases SREBP-1c expression and nuclear abundance by two- to threefold in myotubes. In cultured myotubes, insulin increases the expression of glycolytic and lipogenic enzyme genes and inhibits the 9-cis retinoic acid-induced UCP3 expression. These effects of insulin are mimicked by adenovirus-mediated expression of a transcriptionally active form of SREBP-1c. We conclude that in skeletal muscles, SREBP-1c expression is sensitive to insulin and can transduce the positive and negative actions of the hormone on specific genes and thus has a pivotal role in long-term muscle insulin sensitivity.
Footnotes
-
Address correspondence and reprint requests to Isabelle Guillet-Deniau, Institut Cochin de Génétique Moléculaire, 24 rue du Faubourg St-Jacques, 75014, Paris, France. E-mail: guillet-deniau{at}cochin.inserm.fr.
Received for publication 14 August 2001 and accepted in revised form 27 February 2002.
EDL, extensor digitorum longus; FAS, fatty acid synthase; HK, hexokinase; PPAR, peroxisome proliferator-activated receptor; SREBP, sterol regulatory element binding protein; STZ, streptozotocin.
- DIABETES











